← Back to Search

Affected Subjects for Solid Tumors

N/A
Recruiting
Led By Laura Andres-Martin, PhD
Research Sponsored by New York Stem Cell Foundation Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate cancer research ranging from disease mechanisms to personalized medicine approaches that will help to realize the promise of precision medicine for oncology.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Develop a Laboratory Developed Test (LDT) for CLEP/FDA approval that will inform clinicians of each patient's tumor responses to FDA approved drugs.
Develop stem cells from individual patient samples to study tumor evolution.
Establish functional testing using organoid cultures alone or in combination with additional cell types.
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Healthy ControlExperimental Treatment1 Intervention
Subjects in this group will serve as healthy controls.
Group II: Affected SubjectsExperimental Treatment1 Intervention
Subjects in this group will have a solid tumor cancer diagnosis.

Find a Location

Who is running the clinical trial?

New York Stem Cell Foundation Research InstituteLead Sponsor
5 Previous Clinical Trials
11,436 Total Patients Enrolled
Stevens Institute of TechnologyUNKNOWN
3 Previous Clinical Trials
10,052 Total Patients Enrolled
Laura Andres-Martin, PhDPrincipal InvestigatorNew York Stem Cell Foundation Research Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~333 spots leftby Feb 2034